Navigation Links
Novel 'on-off switch' mechanism stops cancer in its tracks
Date:9/23/2009

A tiny bit of genetic material with no previously known function may hold the key to stopping the spread of cancer, researchers at Yale School of Medicine and Sichuan University in Chengdu, China report in two papers in the September 7-11 issue of Proceedings of the National Academy of Sciences.

In the papers, Alan Garen of the Department of Molecular Biophysics & Biochemistry at Yale and his colleague Xu Song explain how cancer may overcome an organism's natural "stop sign" for cell division.

During early development, stem cells give rise to other cells that differentiate into all types of tissue. New cell division and proliferation stop as the organism matures. However, cancer can hijack this process and trigger the uncontrolled cell division that produces cancer tumors.

One mechanism that stops cell proliferation is a family of tumor-suppressor proteins (TSP) that bind to and block the function of proto-oncogenes, or genes that have the potential to trigger cancer.

Garen's team working with mice found that an RNA molecule from an area of the genome that does not produce proteins prevents a type of TSP from inactivating these incipient cancer genes. The TSP protein they studied, called PSF, is virtually identical in mice and humans, he said.

The Yale team succeeded in preventing the formation of tumors in mice by either increasing the amount of PSF or decreasing the amount of the non-coding RNA in a cell.

"The tumor cell stops proliferating and the tumor regresses in a mouse model of cancer, suggesting that both procedures could be the basis of a clinical protocol," said Garen, who is a member of Yale Cancer Center.

Garen and his colleagues plan to continue their studies on the mechanism that regulates the amount of PSF-binding RNA in a cell, which they believe is central to the origins of cancer.


'/>"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
Source:Eurekalert

Page: 1

Related biology news :

1. University of Miami receives NIH grant to support novel technology for tissue engineering
2. Novel bacterial strains clear algal toxins from drinking water
3. Novel genetic region identified for childhood asthma in Mexicans
4. Novel polymer could improve protein-based drugs
5. Novel mechanism revealed for increasing recombinant protein yield in tobacco
6. La Jolla Institute discovers novel tumor suppressor
7. Got zinc? New zinc research suggests novel therapeutic targets
8. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
9. Novel handheld device detects anthrax with outstanding accuracy and reliability
10. International collaboration by scientists culminates in novel ion channels database
11. UC Davis grant zeroes in on novel asthma diagnosis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology: